The Ahmedabad based 4th largest Indian pharmaceutical company Zydus Cadila has forayed into Spain with the acquisition of 100 per cent stake in Laboratories Combix.
Laboratories Combix which has a pure generics focus provides the right fit for Zydus entry strategy into a market that is estimated at US $1.7 billion and is growing at 21.5 per cent compared to 6 per cent for the overall pharmaceutical market in 2007. The Spanish pharmaceutical market is the fifth largest in Europe.
The details can be read here.
No comments:
Post a Comment